<DOC>
	<DOCNO>NCT02206763</DOCNO>
	<brief_summary>This study evaluate safety , preliminary efficacy , pharmacokinetics ( PK ) momelotinib ( MMB ) erlotinib , well define maximum tolerate dose ( MTD ) momelotinib ( MMB ) combine erlotinib adult epidermal growth factor receptor ( EGFR ) -mutated , EGFR tyrosine kinase inhibitor ( TKI ) naive metastatic non-small cell lung cancer ( NSCLC ) . Participants sequentially enrol receive progressively increase dos MMB combination erlotinib . Escalation MMB dose proceed MTD , define high test dose associate dose-limiting toxicity ( DLT ) first 28 day combine erlotinib MMB treatment . There four dose level treatment cycle consist 28 day .</brief_summary>
	<brief_title>Erlotinib Momelotinib Treatment Epidermal Growth Factor Receptor ( EGFR ) Mutated EGFR Tyrosine Kinase Inhibitor ( TKI ) Naive Metastatic Non-Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Key Metastatic NSCLC document EGFR exon 19 deletion exon 21 ( L858R ) substitution mutation Treatment naive OR one prior standard chemotherapy platinumbased Adequate organ function define follow : Hepatic : Total bilirubin &lt; upper limit normal range ( ULN ) ; aspartate transaminase ( AST ) alanine transaminase ( ALT ) ≤ 3 x ULN Hematological : absolute neutrophil count ( ANC ) ≥1500 cells/mm^3 , platelet ≥ 100,000 cells/mm^3 , hemoglobin ≥ 9.0 g/dL Renal : Serum creatinine &lt; ULN OR calculate creatinine clearance ( CLcr ) ≥ 60 ml/min Eastern Cooperative Oncology Group ( ECOG ) Performance Status 0 , 1 , 2 Key Known positive status human immunodeficiency virus ( HIV ) Chronic active acute viral hepatitis A , B , C infection ( test require hepatitis B C ) Presence &gt; Grade 1 peripheral neuropathy Symptomatic leptomeningeal , brain metastasis , spinal cord compression . History interstitial pneumonitis Note : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>